Sapphire Therapeutics

Trademark details

Sapphire Therapeutics® is a registered trademark used for Full Line of Pharmaceutical and Biopharmaceutical Preparations Technical Consultation, Research, and Development For Others In the Fields of Biotechnology, Genomics, Proteomics, Drug Discovery, Pharmaceutical, Biopharmaceutical and Medicinal Chemistry and owned by Sapphire Therapeutics, Inc.. Full trade mark registration details, registered images and more information below.

View more »

sapphire therapeutics
Goods and/or Services:

Full Line of Pharmaceutical and Biopharmaceutical Preparations Technical Consultation, Research, and Development For Others In the Fields of Biotechnology, Genomics, Proteomics, Drug Discovery, Pharmaceutical, Biopharmaceutical and Medicinal Chemistry

Research and Development of New Products For Others

Scientific Research

Medical Research

Pharmaceutical and Biopharmaceutical Research

Research In the Field of Medicinal Chemistry

Technology Transfer Services, Namely, Licensing of Intellectual Property

more »

Serial Number: 78665702
Filing Date: Jul 7, 2005
Last Applicant(s)/
Owner(s) of Record

Sapphire Therapeutics, Inc.

1031 Us Highway 22, Suite 303
Bridgewater, Nj 08807 US

Related Products:
Pharmaceuticals, Miscellaneous Services; Scientific and technological services, and research and design relating thereto; Industrial analysis and research services; Design and development of computer hardware and software; Legal services

News and Blogs

Total : 2   View more »

News: Helsinn Picks Up Sapphire Therapeutics to Establish U.S. Subsidiary.

...EST Helsinn Picks Up Sapphire Therapeutics to Establish U.S. Subsidiary... Helsinn has bought Sapphire Therapeutics, giving this...operation. “The acquisition of Sapphire Therapeutics will also allow...

News: Sapphire Licenses a Novo Nordisk Program Related to Obesity Therapeutics.

... Sapphire Licenses a Novo Nordisk Program Related to Obesity Therapeutics GEN News Highlights Sapphire Therapeutics licensed a discovery-stage ghrelin antagonist program from Novo Nordisk. These candidates are being researched...

 
 

Explore Related Topics: